Feed Top Reports Pricing

⌘K

16:17:31·65d

SECFiling

SEC Form 10-K filed by NeoGenomics Inc.

NEO· NeoGenomics Inc.

Health Care

Full content unavailable. See the original source below.

Original source

Companies

NEO
NeoGenomics Inc.
Health Care

Recent analyst ratings

Jul 30UpdateBTIG Research-
Jul 29UpdateWilliam Blair-
May 15UpdateGuggenheim-
Apr 30UpdateLeerink Partners$9.00
Jan 13UpdateThe Benchmark Company-
Dec 10UpdateJefferies$22.00

Related

PR16h
NeoGenomics Expands Access to Full Oncology Testing Portfolio Through Epic Aura Integration
PR10d
NeoGenomics to Present Multiple Abstracts Showcasing New Research at AACR Annual Meeting 2026
PR16d
NeoGenomics to Report First Quarter 2026 Financial Results on April 28, 2026
SEC17d
SEC Form DEFA14A filed by NeoGenomics Inc.
SEC17d
SEC Form DEF 14A filed by NeoGenomics Inc.
INSIDER20d
SEC Form 4 filed by Stone Warren
INSIDER20d
SEC Form 4 filed by Zook Anthony P.
SEC27d
Amendment: SEC Form SCHEDULE 13G/A filed by NeoGenomics Inc.

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releases Analyst ratings Insider trading FDA SEC RSS feeds

Top lists

Trending By market cap Active companies Analyst upgrades Insider purchases FDA approvals SEC filings Sectors Market reports

Company

About Pricing Publish with us Contact

Legal

Terms of use Privacy policy Cookie policy

© 2026 quantisnow.com · Democratizing insights since 2022